Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-29 6:01 pm Sale |
2024-12-31 | 13G | Hydrofarm Holdings Group, Inc. HYFM |
Michael Rapoport | 172,839 3.700% |
-60,033 (-25.78%) |
Filing History |
| 2024-03-28 08:00 am Purchase |
2024-03-26 | 13G | Hydrofarm Holdings Group, Inc. HYFM |
Michael Rapoport | 232,872 5.100% |
61,676 (+36.03%) |
Filing History |
| 2022-02-14 1:22 pm Purchase |
2021-12-31 | 13G | Immunome, Inc. IMNM |
Michael Rapoport | 1,181,575 9.600% |
131,086 (+12.48%) |
Filing History |
| 2021-02-10 4:40 pm Purchase |
2020-12-31 | 13G | Immunome, Inc. IMNM |
Michael Rapoport | 1,050,489 9.970% |
1,050,489 (New Position) |
Filing History |
| 2021-02-05 8:34 pm Sale |
2020-12-31 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
Michael Rapoport | 0 0.000% |
-1,490,000 (Position Closed) |
Filing History |
| 2021-01-07 4:07 pm Purchase |
2020-12-31 | 13G | Hydrofarm Holdings Group, Inc. HYFM |
Michael Rapoport | 171,196 5.200% |
171,196 (New Position) |
Filing History |